Börje Ljungberg

Kontakt

borje.ljungberg@umu.se

090-786 72 84, 070-322 76 90

Verksam vid

Professor vid Institutionen för kirurgisk och perioperativ vetenskap Enhet: Urologi och andrologi

10:1, Urologi och andrologi, NUS Urologkliniken, Norrlands universitetssjukhus, 901 85 Umeå

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease: A National Register Study

European Urology Open Science, Vol. 39 : 22-28

Almadalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; et al.

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

European Urology, Elsevier 2022, Vol. 81, (2) : 134-137

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years

PLOS ONE, Public Library of Science 2022, Vol. 17, (1)

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic

European Journal of Cancer Prevention, Lippincott Williams & Wilkins 2022, Vol. 31, (3) : 228-234

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

European Urology Open Science, Elsevier 2022, Vol. 40 : 38-45

Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; et al.

European Association of Urology Guidelines on Renal Cell Carcinoma: the 2022 Update

European Urology

Ljungberg, Börje; Albiges, Laurence; Abu-Ghanem, Yasmin; et al.

Inflammatory response markers and survival prediction in patients with renal cell carcinoma

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 47-52

Mountzias, Alexander; Hultdin, Johan; Hlodan, Jan; et al.

Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

BJU International, John Wiley & Sons 2021, Vol. 128, (3) : 386-394

Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery: Results from RECUR Consortium

European Urology Oncology, Elsevier 2021, Vol. 4, (3) : 473-482

Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care

European Urology, Elsevier 2021, Vol. 80, (4) : 393-397

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

European Urology, Elsevier 2021, Vol. 79, (3) : 339-342

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature

European urology oncology, Elsevier 2021, Vol. 4, (1) : 22-41

Campi, Riccardo; Stewart, Grant D.; Staehler, Michael; et al.

The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium

PLoS Medicine, Public Library of Science (PLOS) 2021, Vol. 18, (9)

Guida, Florence; Tan, Vanessa Y.; Corbin, Laura J.; et al.

Soft drink and juice consumption and renal cell carcinoma incidence and mortality in the european prospective investigation into cancer and nutrition

Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research 2021, Vol. 30, (6) : 1270-1274

Heath, Alicia K.; Clasen, Joanna L.; Jayanth, Nick P.; et al.

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor

BMC Cancer, BioMed Central 2021, Vol. 21, (1)

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden

PLOS ONE, Public Library of Science 2021, Vol. 16

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Patient-reported outcome measures of abdominal wall morbidity after flank incision for open partial nephrectomy

BJU International, John Wiley & Sons 2021, Vol. 128, (4) : 497-503

Inkiläinen, Aapo; Blomqvist, Lennart; Ljungberg, Börje; et al.

Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy

World journal of urology, Springer Nature 2021, Vol. 39, (9) : 3377-3383

Kuusk, Teele; Klatte, Tobias; Zondervan, Patricia; et al.

Validation of data quality in the National Swedish Kidney Cancer Register

Scandinavian journal of urology, Taylor & Francis Group 2021, Vol. 55, (2) : 142-148

Landberg, Anna; Bruce, Daniel; Lindblad, Per; et al.

A tactile resonance sensor for prostate cancer detection - Evaluation on human prostate tissue

Biomedical Engineering & Physics Express, Institute of Physics (IOP) 2021, Vol. 7, (2)

Lindahl, Olof A; Bäcklund, Tomas; Ramser, Kerstin; et al.

Radical Nephrectomy: The Widening Gap Between Evolution of Technique and Evidence

European Urology, Elsevier 2021, Vol. 80, (4) : 440-441

Ljungberg, Börje; Bex, Axel

Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials

Clinical Genitourinary Cancer, Elsevier 2021, Vol. 19, (2) : e92-e99

Marconi, Lorenzo; Sun, Maxine; Beisland, Christian; et al.

Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma

World journal of urology, Springer-Verlag New York 2021, Vol. 39, (10) : 3823-3831

Neves, Joana B.; Vanaclocha Saiz, Leyre; Abu-Ghanem, Yasmin; et al.

A psychometric evaluation of the Functional assessment of cancer therapy—kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure

Quality of Life Research, Springer Netherlands 2021, Vol. 30, (9) : 2663-2670

Rosenblad, Andreas Karlsson; Sundqvist, Pernilla; Westman, Bodil; et al.

Risk prediction for renal cell Carcinoma: Results from the European Prospective Investigation into Cancer and nutrition (EPIC) prospective cohort study

Cancer Epidemiology, Biomarkers and Prevention, AACR 2021, Vol. 30, (3) : 507-512

Singleton, Rosie K.; Heath, Alicia K.; Clasen, Joanna L.; et al.

Significance of PI3K Signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status

Journal of Clinical Pathology, BMJ Publishing Group Ltd 2021, Vol. 74, (4) : 216-222

Tumkur Sitaram, Raviprakash; Landström, Maréne; Roos, Göran; et al.

Increased risk for renal cell carcinoma in end stage renal disease: a population-based case-control study

Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (3) : 209-214

Åkerlund, John; Holmberg, Erik; Lindblad, Per; et al.

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel

European Urology Oncology, Elsevier 2020, Vol. 3, (4) : 423-442

Abu-Ghanem, Yasmin; Fernandez-Pello, Sergio; Bex, Axel; et al.

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma

Journal of Translational Medicine, Vol. 18, (1)

Andersson-Evelönn, Emma; Vidman, Linda; Källberg, David; et al.

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel

European Urology Oncology, Elsevier 2020, Vol. 3, (1) : 57-72

Fernández-Pello, Sergio; Hora, Milan; Kuusk, Teele; et al.

Targeted therapy for metastatic renal cell carcinoma

Cochrane Database of Systematic Reviews, John Wiley & Sons 2020, (10)

Hofmann, Fabian; Chang Hwang, E.; Lam, Thomas B.L.; et al.

Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer

Urologic Oncology, Elsevier 2020, Vol. 38, (5) : 521-525

Kuusk, Teele; Zondervan, Patricia; Lagerveld, Brunolf; et al.

The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma research

Scandinavian journal of urology, Taylor & Francis 2020, Vol. 54, (3) : 235-240

Landberg, Anna; Lindblad, Per; Harmenberg, Ulrika; et al.

A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma

Journal of Clinical Oncology, American Society of Clinical Oncology 2020, Vol. 38, (5)

Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; et al.

Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting

Scandinavian journal of urology, Taylor & Francis 2020, Vol. 54, (6) : 487-492

Ljungberg, Börje; Sundqvist, Pernilla; Lindblad, Per; et al.

Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk: A Prospective Study in the EPIC Cohort

Cancer Epidemiology, Biomarkers and Prevention, Philadelphia: American Association of Cancer Research 2020, Vol. 29, (8) : 1654-1664

Lujan-Barroso, Leila; Botteri, Edoardo; Caini, Saverio; et al.

European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era

European Urology, Elsevier 2020, Vol. 78, (1) : 21-28

Ribal, Maria J.; Cornford, Philip; Briganti, Alberto; et al.

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

New England Journal of Medicine, Massachusetts Medical Society 2020, Vol. 382, (23) : 2197-2206

Sternberg, Cora N.; Fizazi, Karim; Saad, Fred; et al.

Role of Wnt Signaling Pathways in Clear Cell Renal Cell Carcinoma Pathogenesis in Relation to VHL and HIF Status

Clinical Oncology and Research, Vol. 3, (3)

Tumkur Sitaram, Raviprakash; Landström, Maréne; Roos, Göran; et al.

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

European Urology, Elsevier 2019, Vol. 76, (2) : 151-156

Albiges, Laurence; Powles, Tom; Staehlerr, Michael; et al.

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

BMC Cancer, BioMed Central 2019, Vol. 19

Andersson Evelönn, Emma; Landfors, Mattias; Haider, Zahra; et al.

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma

Frontiers in Oncology, Frontiers Media S.A. 2019, Vol. 9

Bergerot, Cristiane Decat; Battle, Dena; Bergerot, Paulo Gustavo; et al.

Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR)

European Urology, Elsevier 2019, Vol. 75, (2) : 261-264

Dabestani, Saeed; Beisland, Christian; Stewart, Grant D.; et al.

Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized RCC: results from a European multicenter database (RECUR)

Scandinavian journal of urology, Taylor & Francis Group 2019, Vol. 53, (1) : 14-20

Dabestani, Saeed; Beisland, Christian; Stewart, Grant D.; et al.

Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis

European Urology Focus, Elsevier 2019, (5) : 857-866

Dabestani, Saeed; Beisland, Christian; Stewart, Grant D.; et al.

Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019

European Urology, Elsevier 2019, Vol. 76, (3) : 368-380

Grimm, Marc-Oliver; Bex, Axel; De Santis, Maria; et al.

The influence of obesity-related factors in the etiology of renal cell carcinoma: A mendelian randomization study

PLoS Medicine, Public Library of Science 2019, Vol. 16, (1)

Johansson, Mattias; Carreras-Torres, Robert; Scelo, Ghislaine; et al.

Patient's QoL after open kidney surgery in a randomized study of spinal versus epidural analgesia in patients with renal cell carcinoma

Scandinavian journal of urology, Taylor & Francis 2019, Vol. 53 : 17-17

Kroger Dahlin, Britt-Inger; Thurm, Mascha; Winsö, Ola; et al.

Sex specific associations in genome wide association analysis of renal cell carcinoma

European Journal of Human Genetics, Nature Publishing Group 2019, Vol. 27, (10) : 1589-1598

Laskar, Ruhina S; Muller, David C; Li, Peng; et al.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

European Urology, Vol. 75, (5) : 799-810

Ljungberg, Börje; Albiges, Laurance; Abu-Ghanem, Yasmin; et al.

Visa publikationer i DiVA

Forskningsprojekt

1 januari 2018

Börje Ljungberg projekt